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ABSTRACT
The Protein Ontology (PRO; http://proconsortium.
org) formally defines protein entities and explicitly
represents their major forms and interrelations.
Protein entities represented in PRO corresponding
to single amino acid chains are categorized by
level of specificity into family, gene, sequence and
modification metaclasses, and there is a separate
metaclass for protein complexes. All metaclasses
also have organism-specific derivatives. PRO com-
plements established sequence databases such as
UniProtKB, and interoperates with other biomedical
and biological ontologies such as the Gene
Ontology (GO). PRO relates to UniProtKB in that
PRO’s organism-specific classes of proteins
encoded by a specific gene correspond to entities
documented in UniProtKB entries. PRO relates to
the GO in that PRO’s representations of organism-
specific protein complexes are subclasses of the
organism-agnostic protein complex terms in the
GO Cellular Component Ontology. The past few
years have seen growth and changes to the PRO,
as well as new points of access to the data
and new applications of PRO in immunology and
proteomics. Here we describe some of these
developments.
INTRODUCTION
Scientiﬁc discourse is predicated on mutual understand-
ing, veriﬁcation of information and the inference of new
connections. Ontologies facilitate such discourse by
providing formal deﬁnitions of and disambiguation for
entities of interest. In addition, placing entities in an onto-
logical context facilitates the ability to make connections
over short and long ranges within and between networks.
It is toward these goals that the Open Biological and
Biomedical Ontologies (OBO) Foundry was created (1).
The Protein Ontology (PRO) is an OBO Foundry
ontology that deﬁnes classes of proteins and explicitly in-
dicates how these classes interrelate. The (intended) scope
of PRO is the totality of naturally occurring protein
entities. PRO has been used to deﬁne dendritic and hem-
atopoietic cell types (2,3), to describe biological processes,
to ﬂag protein entities mentioned in the literature (4) and
to capture information isolated from the literature in text
mining workﬂows (5,6).
Classes deﬁned in PRO range in speciﬁcity from protein
families to classes whose member proteins have speciﬁc
post-translational modiﬁcations, are part of speciﬁc
complexes, and which occur in speciﬁc organisms. The
levels of speciﬁcity form the basis for categorizing PRO
terms [(Figure 1; fully described in (7)]. Brieﬂy, each PRO
term categorized as ‘family-level’ refers to the class of
proteins translated from a speciﬁc set of ancestrally
related genes. A PRO term categorized as ‘gene-level’
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refers to the class of proteins translated from a different
gene related by 1:1 orthology in distinct organisms. Each
term categorized as ‘sequence-level’ refers to the class of
proteins translated from a speciﬁc mRNA of a given gene
or from a speciﬁc translation start site. A term categorized
as ‘modiﬁcation-level’ refers to the class of all proteins
modiﬁed in some speciﬁc way, either by amino acid modi-
ﬁcation or by proteolytic cleavage. And ﬁnally a term
categorized as ‘complex’ refers to the class of complexes
with a speciﬁc deﬁned subunit composition. PRO makes
no distinction between complexes whose components are
modiﬁed before—or after—complex formation, and all
complexes are grouped into the ‘complex’ category regard-
less of the speciﬁcity of their components.
As an OBO Foundry ontology, PRO is dedicated
to interoperability not only with other ontologies but
also with existing protein-related resources such as
UniProtKB (8). For example, each organism-agnostic
category described earlier in text also has organism-
speciﬁc subcategories, so an ‘organism-gene’ PRO term
would denote any translation product of a speciﬁc gene
in a single organism. The latter, of course, are precisely
what UniProtKB entries represent. Thus, PRO both uses
UniProtKB and complements it by providing formal def-
initions for protein entities and placing the terms in an
ontological context. PRO makes use of ontology resources
such as PSI-MOD (9) and SO (10) to deﬁne protein classes
of the modiﬁcation category. PRO also makes use of com-
munity orthology sets with persistent accession numbers
to provide the ability to group related proteins across
the organisms represented in PRO. These sets are used
to make connections between UniProtKB and PRO,
with speciﬁc connections given in the form of a mapping
between accessions from the two resources (7). In
addition, the organism-speciﬁc protein complexes deﬁned
in PRO extend the (parental) hierarchy found in the Gene
Ontology (GO) Cellular Component Ontology (11), the
protein complex branch of which corresponds to PRO’s
‘complex’ category. The organism-agnostic complexes of
GO thus provide parent terms for PRO’s organism-
speciﬁc complex terms and provide the basis for connect-
ing and comparing complexes between organisms.
The past few years have seen growth and changes to
the ontology, as well as new points of access to the data
and new applications. Here we describe some of these
developments.
Figure 1. Illustration of PRO categories and relation to external resources. Categories (aka metaclasses) are listed along the top, with example terms
for IRF5 (interferon regulatory factor 5) shown directly below. Circles denote protein terms, whereas squares denote protein complex terms. For
each, blue indicates terms that are deﬁned in an organism-agnostic way; green indicates terms that are organism-speciﬁc. Solid lines show is_a
relationships and broken lines show has_component relationships (though the complexes in this example have components in the modiﬁcation
category, this need not be the case). Filled circles and ﬁlled squares indicate how UniProtKB and GO, respectively, ﬁt into the hierarchy. Not all
terms and relationships are shown. IRF, interferon regulatory factor; Phos, phosphorylated; m, mouse; h, human; iso, isoform; BMv, bone marrow
variant.
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ENHANCEMENTS OF DATA AND COVERAGE
Reference organisms
Terms in the gene category comprise the largest metaclass
within PRO. Terms in this metaclass are typically deﬁned
with respect to a gene in a reference organism, and the
class of proteins covered by the term includes all transla-
tion products not only of that gene in that organism but
also of any of its 1:1 orthologs in other organisms. Until
2012, when PRO deﬁned terms using only human, mouse
and Escherichia coli as references, users could reliably
discern the reference organism from the gene name (the
casing of which differs for each of the three organisms).
For example, a protein deﬁned as the translation product
of the ADA gene (PR:000003707) meant the human ADA
(adenosine deaminase) gene and its 1:1 orthologs, not the
translation product of the E. coli ada (bifunctional tran-
scriptional activator/DNA repair enzyme Ada) gene
(PR:000022054) and its 1:1 orthologs. However, the
addition of terms using other organisms as a reference
(see later in text) has rendered this mechanism inadequate,
especially since non-orthologous genes in different organ-
isms can be given the same designation even in standard
nomenclatures. For example, tubulin–tyrosine ligase
(PR:000016788) is deﬁned with respect to the human
TTL gene, whereas uric acid degradation bifunctional
protein TTL (PR:000035855) is deﬁned with respect
to the Arabidopsis thaliana TTL gene. In general, model
organisms with well-established nomenclatures are used as
references; preference is given to human, whereas E. coli
is used for prokaryote-only classes, Saccharomyces
cerevisiae for fungi-only classes and A. thaliana for
plant-only classes.
Mappings to external databases
We have improved, formalized and expanded the mapping
of accessions from external databases to PRO identiﬁers.
The majority of mapped accessions for protein records is
from UniProtKB (http://www.uniprot.org), Reactome
(http://www.reactome.org/) and EcoCyc (http://ecocyc.
org/) databases. In addition, we provide gene record
mappings from Mouse Genome Informatics (MGI; http://
www.informatics.jax.org/), HUGO Gene Nomenclature
Committee (HGNC; http://www.genenames.org/),
EcoGene (http://ecogene.org/), PomBase (http://www.
pombase.org/) and the Saccharomyces Genome Database
(SGD; http://www.yeastgenome.org/). Previously these
mappings were given only in a tab-delimited ﬁle that
contains very limited information; now, however, they
have also been formalized and expanded into a supplemen-
tary OBO-format ﬁle (promapping.obo, see later in text)
that contains complete deﬁnitions of and relationships
between the mapped terms. For example, we indicate
that human follistatin protein (UniProtKB:P19883) is a
subtype of follistatin protein found in any organism
(PR:000000015) and is encoded by the human follistatin
gene FST (HGNC:3971). The PRO mappings, which pre-
viously covered only three organisms (human, mouse and
E. coli), now cover 12 GO reference proteomes (12):
human, mouse, rat, zebraﬁsh, chicken, fruit ﬂy, budding
yeast, ﬁssion yeast, E. coli, A. thaliana, Caenorhabditis
elegans and Dictyostelium discoideum. Assignment of each
organism-speciﬁc protein to a PRO organism-agnostic gene
category term is done (largely) automatically using 1:1
ortholog inferences provided by OMA (13). Mapping
statistics for each release are provided at the PRO website.
Reuse of UniProtKB accessions
PRO reuses external ontology identiﬁers whenever
feasible. Thus, if a required term is already deﬁned in
another ontology, PRO uses that term without changing
its identiﬁer (i.e. we do not create an identical term and
assign a PRO identiﬁer to it). However, much information
in the protein ﬁeld is available in the UniProtKB database,
with established and stable accessions. Therefore, when we
incorporate UniProtKB entries into the PRO ‘organism-
gene’ category (Figure 1, ﬁlled green circles), in the interest
of minimizing the minting of new identiﬁers, we use
UniProtKB accession identiﬁers directly, preﬁxing them
with ‘PR:’ as in the example PR:P19883 (‘http://purl.
obolibrary.org/obo/PR_P19883’ for the URL). All such
entries are cross-referenced back to the originating
database, using ‘UniProtKB:’ as the preﬁx, as in the
example ‘UniProtKB:P19883’ (‘http://www.uniprot.org/
uniprot/P19883’ for the URL). In this way, the database
and ontological representations of P19883 are clearly
distinguished. In the future, use of UniProtKB isoform
identiﬁers (of the form P19883-1) will be adopted.
NEW COLLABORATIONS AND AREAS
OF APPLICATION
ImmPort
PRO Consortium scientists are working with scientists at
Stanford within the framework of the Bioinformatics
Integration Support Contract (BISC) and the Human
Immunology Project Consortium (HIPC; http://www.
immuneproﬁling.org/hipc/page/show). The goal of BISC
is to collect and house data in the Immunology and Data
Analysis Portal (ImmPort) and to make these data access-
ible on the web. An important part of ImmPort’s data and
of the associated work by HIPC scientists derives from the
application of the innovative CyTOF technique, a vari-
ation of mass cytometry in which antibodies are labeled
with heavy metal ion tags rather than with ﬂuorochromes
to allow single samples to be probed simultaneously with
many antibodies (14). This, however, creates challenges
for cell typing, as for many cell populations the CyTOF-
generated data go far beyond our current knowledge.
The Cell Ontology (15) deﬁnes cell types. To enhance
the utility of the CL to support automated analyses of cell
types, an enhanced association of markers to particular
cell types is needed, so that each cell type is associated
with all markers it is known to express. A problem
arises here because immunologists typically use multiple
different names for the proteins identiﬁed in their experi-
ments. PRO is thus used as controlled vocabulary to yield
consistent data for analysis while at the same time
providing complete lists of synonyms associated with
proteins of interest to allow for proper mapping of the
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data (Table 1). In addition, because practitioners of ﬂow
cytometry and CyTOF use antibodies as primary reagents
to detect cellular markers, an adequate analysis and inte-
gration of their data requires a comprehensive mapping of
antibodies to the proteins they detect. We are curating a
mapping between such antibodies and PRO IDs, thereby
indicating the speciﬁc modiﬁcations that might be targeted
in experiments and reference to the appropriate level of
speciﬁcity. For example, anti-CD45 monoclonal antibody
clone HI30 recognizes all isoforms of the CD45 marker,
whereas HI100 recognizes only the CD45RA isoform
(Table 1). Src provides another example. Anti-Src clone
3828 recognizes only human Src of all forms, whereas
K98-37 recognizes only the form phosphorylated
(at least) on tyrosine-418 (human numbering); it is,
however, predicted to cross-react with the corresponding
form in other species.
Proteoform repository
The PRO Consortium is collaborating with the top-down
proteomics community from Northwestern University
(http://www.topdownproteomics.org/). The top-down
proteomics approach focuses on intact protein molecules,
rather than their pieces. Thus, results more accurately
reﬂect the structures and properties of proteins in actual
biological systems than do results using a bottom-up
proteomics approach (16) and allow the identiﬁcation of
multiple simultaneous modiﬁcations. The Proteoform
Repository is a database that contains experimentally
veriﬁed proteoforms—isoforms and post-translationally
modiﬁed forms—from various cell types in three model
organisms (human, mouse and yeast) (17). PRO
provides the corresponding ontological representations
with links to this data source (e.g. PR:000036126). The
formal representation of proteoforms in PRO will enable
(i) the study of conserved modiﬁcations among these or-
ganisms, (ii) the association to functional information
and (iii) uncovering relations between proteoforms. In
addition, inclusion of the metadata related to the cell
type(s) where the proteoforms were identiﬁed will allow
comparison among different cell types or in normal versus
disease states. PRO Release 37 contains 194 proteoforms
encoded by 164 genes. Eighteen were found to be
conserved between human and mouse. Considering only
the highest conﬁdence subset of the current repository
data, we expect to integrate >700 proteoforms, 400 of
which contain multiple modiﬁcations.
Representations of biological pathways using PRO
PRO provides unique identiﬁers for each form of proteins
and protein complexes, and thus it is a useful resource
for those seeking to represent pathways—particularly
signaling and regulatory pathways—which often involve
changes in post-translational modiﬁcation of proteins and
differences in composition of complexes. Moreover, the
organization of protein forms by orthology in PRO
enables cross-species comparisons (6,18). Recently, PRO
has been used to describe two such pathways: Toll-like
receptor signaling and the spindle checkpoint.
TLRs are transmembrane receptors that facilitate
recognition of microbial molecules. Activation of the
receptors induces an intricate chain of protein–protein
interactions regulated by the recruitment of different
intracellular adaptors. Furthermore, the pathways are
not linear; they can diverge or merge to produce synergis-
tic responses that are not predictable from the output
evoked by an individual canonical pathway. The spindle
checkpoint maintains genomic integrity during mitosis
and meiosis by inhibiting chromosome segregation until
all chromosomes have been correctly attached to the
spindle. Checkpoint signaling involves numerous protein
phosphorylation events. One key checkpoint protein,
BUB1B, is phosphorylated on at least 12 different sites
by three different protein kinases. Four phosphorylated
forms of BUB1B are deﬁned in PRO, each phos-
phorylated on a different biologically relevant subset of
the 12 sites. Each form is functionally annotated to
describe its characteristic protein–protein interactions
and role in the spindle checkpoint and related processes.
Ambiguous protein forms
PRO can represent both intentional ambiguity (e.g. a
complex can include any one of a family of proteins (19)
and genuine uncertainty (e.g. a protein is known to be
phosphorylated but the identity of the modiﬁed residue
is unknown) for protein forms. The ability to do so has
practical applications in scientiﬁc discourse, as it is some-
times necessary to refer to collections of objects made
Table 1. Portion of antibody registry
Marker Alternative names Clone PRO Scope
CD45 PTPRC, B220, gp180,
LCA, leukocyte common
antigen, Ly-5, Lyt-4,
lymphocyte antigen 5, T200
HI30 PR:000001006 All forms of CD45 (human+)
CD45RA HI100 PR:000001015 Isoform RA (human+)
CD45RB MT4 (6B6) PR:000001016 Isoform RB (human+)
CD45R0 UCHL1 PR:000001017 Isoform RO (human+)
Src SRC1, ASV, c-src 3828 PR:P12931 All forms of Src (human)
Src (pY418) K98-37 PR:000027237 Any Src phosphorylated on Y418 (human)
Shading in the marker column indicates that the named marker includes the shown forms. For example, CD45RA is one isoform of CD45. Shading
in the clone column indicates that the clone recognizes the shown subtypes. Shading in the PRO column indicates that the shown classes are
subtypes. The Scope column indicates what forms are included in the PRO class. Not all alternative names and clones are shown.
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either for the sake of convenience or to express incomplete
knowledge. One example of this is osteocalcin peptide,
which exists in three forms that are distinguished by
the carboxylation state of three speciﬁc glutamic acid
(glu) residues (which can be converted to gamma-
carboxyglutamic acid, gla) (20,21). Fully carboxylated
osteocalcin contains three gla residues, the under-
carboxylated form contains one or two and the
uncarboxylated form contains none. Assays can distin-
guish between the three, but cannot distinguish between
the possible undercarboxylated forms. PRO thus contains
a general term for undercarboxylated osteocalcin
(PR:000024926), deﬁned as containing a minimum of
one gla residue and a maximum of two, without indicating
the positions of modiﬁcation.
NEW WEB VIEWS AND RESOURCES
Organism–gene summary view
Annotation efforts are focusing more and more on
capturing information at speciﬁc levels. For example, the
GO Consortium has modiﬁed its policies and data ﬁles so
curators can indicate the precise form of a gene product
for which an indicated annotation applies, be it a speciﬁc
isoform or a post-translationally modiﬁed form.
Accordingly, we have enhanced the web view for terms
in the organism–gene metaclass. Whereas the web view
previously displayed information pertaining solely to the
displayed term, the new view presents all the products of a
speciﬁc gene (corresponding, in most cases, to a single
UniProtKB entry) and presents all the annotation
associated with each product (Figure 2). Scientists can
thus compare these different products directly, either
using the GO-centric view (middle panel), where the
relevant products of the gene are mapped to each GO
annotation, or the PRO-centric view (bottom panel),
where the relevant GO annotations are shown for each
gene product. For example, mouse interferon regulatory
factor 8, encoded by the Irf8 gene (MGI:96395; protein
sequence given in UniProtKB: P23611), can be sumoy-
lated. When in the unsumoylated form (PR:000035709),
the protein can positively regulate RNA polymerase II
transcription initiation (GO:0060261). The sumoylated
form (PR:000035707), however, cannot. This difference
is made clear by the new view. The approach described
here for GO will be extended to other ontologies that are
used for describing other attributes of PRO terms, such as
involvement in disease, and absence or presence of protein
domains.
Figure 2. Display for protein products of the mouse Irf8 gene. Top panel, deﬁned PRO terms; Middle panel, GO-centric view of annotations;
Bottom panel, PRO-centric view of the annotations.
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Cytoscape view
PRO now features a Cytoscape view that provides an
interactive and visual interpretation of PRO terms and
their relations. The view can be accessed via the
Cytoscape icon displayed on PRO search results pages
and entry reports. Cytoscape supports searches and cus-
tomization of the layout and display; displays links to
PRO entry pages, OBO stanzas and annotations; and
allows saving of the network ﬁgure in PNG format.
Networks pertinent to a single entry or to multiple
entries selected from search results pages can be shown.
The default view displays the hierarchical relationships for
parents, siblings and children of the requested entries. For
complexes, the hierarchies for both the complexes and the
complex components are displayed. For example, Figure 3
shows the Cytoscape view for complexes containing the
kinase, BUB1 and a related kinase BUB1 beta (aka
BUBR1) in either the unphosphorylated form (upper
part) or one possible phosphorylated form (lower part).
The ﬁgure illustrates how analogous complexes in another
organism can be inferred based on the displayed network.
For example, one can follow has_component relationships
for the unphosphorylated version of the human complex
to see that each of its components—human BUB1 and
human unphosphorylated BUB1 beta—has a counterpart
in Xenopus laevis [follow the is_a relationship to the
organism-agnostic form (blue circles), then back down
the other branch to the Xenopus version]. The conserva-
tion of components could indicate that Xenopus too has
such a complex, though currently experimental evidence is
lacking.
ACCESS TO PRO
PRO is accessible via the Internet at http://proconsortium.
org. The home page includes a brief overview of the
ontology and links to search and browse functions, statis-
tics, documentation/tutorials, term request and annota-
tion pages and downloads.
Downloadable ﬁles include the main PRO OBO ﬁle
(pro.obo), a supplementary OBO ﬁle containing terms for
mapped entries from external databases (promapping.obo),
the PRO annotation ﬁle (PAF.txt) and a tab-delimited
mapping ﬁle (promapping.txt). In addition to the two
OBO ﬁles indicated earlier in text, versions of the OBO
ﬁles to which logical reasoning has been applied are avail-
able (pro_reasoned.obo and promapping_reasoned.obo).
The reasoned ﬁles, produced using the ELK reasoner of
the OBO Ontologies Release Tool (http://code.google.
com/p/owltools/wiki/OortIntro), contain additional
inferred relations that, for brevity and simplicity, are not
explicit in the non-reasoned versions. Before reasoning, all
PRO terms are deﬁned using a single-parent hierarchy; rea-
soning in some cases adds new parent terms.
Links to PRO terms can be made using the general
form http://purl.obolibrary.org/obo/PR_xxx, where xxx
denotes either a nine-character numeric string for
the traditional PRO identiﬁer or a six-character alpha-
numeric string indicating a UniProtKB accession.
Figure 3. Cytoscape view of BUB1:BUB1B complexes. The is_a relationship between child and parent in the PRO hierarchy and the has_component
relationship between complexes and their components are shown by black arrows and blue dotted arrows, respectively. Clicking on a node (e.g. frog-
BUB1B/Phos:2) brings a pop-up box that provides details and allows additional actions. Only a subset of nodes is shown, which have been
rearranged for clarity.
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UniProtKB-derived PRO terms are cross-referenced from
within the corresponding UniProtKB entries.
Users can request PRO terms or contribute to the
curation of PRO terms. The PRO Tracker (Sourceforge)
is the main mechanism for requesting new terms or modi-
ﬁcation of existing ones. RACE-PRO (22) is a user-
friendly interface that allows the addition of experimental
information to PRO terms, and therefore fosters contri-
bution by domain experts.
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